subject: PUBCHEM.COMPOUND:10458325

object_name: Recurrent Glioblastoma


subject: PUBCHEM.COMPOUND:10458325

subject_name: tesevatinib

object_name: glioblastoma

tested_intervention: unsure


subject: PUBCHEM.COMPOUND:10458325

object_name: Childhood Glioblastoma


subject: PUBCHEM.COMPOUND:10458325

object_name: adult glioblastoma


subject: PUBCHEM.COMPOUND:10458325

object_name: brain neoplasm


subject: CHEBI:167674

subject_name: Tesevatinib

object_name: Recurrent Childhood Glioblastoma


subject: CHEBI:167674


subject: CHEBI:167674


subject: CHEBI:167674


subject: CHEBI:167674


subject: CHEBI:167674


subject: UMLS:C0354100

subject_name: Loop Diuretics

object_name: heart failure


subject: UMLS:C0354100

object_name: congestive heart failure


subject: UMLS:C0042402

subject_name: Vasodilator Agents


subject: UMLS:C0042402


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: UMLS:C0304509

subject_name: Inotropic agent (substance)


subject: UMLS:C0304509


subject: UMLS:C0042397

subject_name: Vasoconstrictor Agents


subject: UMLS:C0042397


subject: UMLS:C5433403

subject_name: Forxiga


subject: UMLS:C5433403


subject: CHEBI:85078

subject_name: Dapagliflozin


subject: MESH:C484361

subject_name: karinat

object_name: Menopausal syndrome

tested_intervention: yes


subject: CHEBI:177425

subject_name: Patidegib

object_name: Recurrent Malignant Head and Neck Neoplasm


subject: UNII:E3B2GI648A

subject_name: Belatacept

object_name: kidney disorder


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: Resorption of tooth or root


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: UNII:JWF5YAW3QW

subject_name: Valerian

object_name: Depressed mood


subject: UMLS:C3495130

subject_name: Passiflora incarnata homeopathic preparation


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: peripheral nervous system disorder


subject: CHEBI:7986

object_name: neuropathy


subject: CHEBI:135285

subject_name: Vildagliptin

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:135285

object_name: metabolic syndrome X


subject: CHEBI:94793

subject_name: Pimasertib

object_name: pancreatic adenocarcinoma


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan

object_name: lung cancer


subject: PUBCHEM.COMPOUND:156963654

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:156963654

object_name: lung carcinoma


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UNII:3JB47N2Q2P

subject_name: Natalizumab

object_name: schizophrenia


subject: UMLS:C0665297

subject_name: natalizumab


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: Elbow Tendinopathy


subject: CHEBI:61848


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: PR:000001886

subject_name: major prion protein


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000013555

subject_name: proline-rich protein 2


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: ovarian carcinoma


subject: CHEBI:89324

object_name: malignant epithelial tumor of ovary


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Osteoarthritis of glenohumeral joint


subject: CHEBI:41423

object_name: osteonecrosis


subject: CHEBI:41423

object_name: avascular necrosis


subject: CHEBI:41423

object_name: Ischemic Necrosis


subject: CHEBI:41423

object_name: Avascular Necrosis, CTCAE


subject: CHEBI:42797

subject_name: Gabapentin


subject: CHEBI:42797

object_name: arthritis


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:42797


subject: UMLS:C0360094

subject_name: iv lidocaine

object_name: opioid use


subject: UMLS:C0360094


subject: UMLS:C0360094


subject: UMLS:C0360094


subject: UMLS:C0360094


subject: UMLS:C0360094


subject: UMLS:C0360094


subject: UMLS:C0360094

object_name: rotator cuff syndrome


subject: UMLS:C0360094

object_name: Rotator cuff tear


subject: CHEBI:46195

subject_name: Acetaminophen


subject: CHEBI:46195


subject: CHEBI:46195


subject: CHEBI:46195


subject: CHEBI:46195


subject: CHEBI:46195


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: CHEBI:4445

subject_name: Desflurane


subject: CHEBI:4445


subject: CHEBI:4445


subject: CHEBI:4445


subject: CHEBI:4445


subject: CHEBI:4445


subject: CHEBI:4445


subject: CHEBI:4445


subject: CHEBI:4445


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: CHEBI:44915


subject: CHEBI:44915


subject: CHEBI:44915


subject: CHEBI:44915


subject: CHEBI:44915


subject: CHEBI:8884

subject_name: Rocuronium


subject: CHEBI:8884


subject: CHEBI:8884


subject: CHEBI:8884


subject: CHEBI:8884


subject: CHEBI:8884


subject: CHEBI:8884


subject: CHEBI:8884


subject: CHEBI:8884


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: CHEBI:9130


subject: CHEBI:9130


subject: CHEBI:9130


subject: CHEBI:9130


subject: CHEBI:9130


subject: CHEBI:9130


subject: CHEBI:9130


subject: UMLS:C0146226

subject_name: Toradol


subject: UMLS:C0146226


subject: UMLS:C0146226


subject: UMLS:C0146226


subject: UMLS:C0146226


subject: UMLS:C0146226


subject: UMLS:C0146226


subject: UMLS:C0146226


subject: CHEBI:6129

subject_name: Ketorolac


subject: CHEBI:6129


subject: CHEBI:6129


subject: CHEBI:6129


subject: CHEBI:6129


subject: CHEBI:6129


subject: CHEBI:9939

subject_name: Vecuronium


subject: CHEBI:9939


subject: CHEBI:9939


subject: CHEBI:9939


subject: CHEBI:9939


subject: CHEBI:9939


subject: CHEBI:9939


subject: CHEBI:9939


subject: CHEBI:9939


subject: CHEBI:42797

object_name: idiopathic scoliosis


subject: PUBCHEM.COMPOUND:23279496

subject_name: uridine triacetate

object_name: Harmful pattern of use of methamphetamine


subject: PUBCHEM.COMPOUND:23279496

object_name: Harmful pattern of substance use


subject: PUBCHEM.COMPOUND:23279496

object_name: substance abuse


subject: PUBCHEM.COMPOUND:23279496

object_name: Addiction


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Malignant melanoma stage III


subject: CHEBI:231679

object_name: Malignant melanoma stage IV


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS

object_name: Atypical behavior


subject: UNII:71M78END5S

object_name: Disturbances in initiating and maintaining sleep


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:25681


subject: UMLS:C1446715

subject_name: Phoenix dactylifera antigen

object_name: Dyslipidemia


subject: UMLS:C1446715

object_name: Decreased liver function


subject: UMLS:C1446715

object_name: Increased reactive oxygen species production


subject: UMLS:C1446715

object_name: sickle cell-hemoglobin c disease syndrome


subject: UMLS:C1446715

object_name: hyperglycemia


subject: UMLS:C1446715

object_name: Hyperglycemia, CTCAE


subject: UMLS:C1446715

object_name: Glucose in blood specimen above reference range


subject: UMLS:C1446715

object_name: anemia


subject: UMLS:C1446715

object_name: Anemia, CTCAE


subject: CHEBI:46195

object_name: Emergence Delirium


subject: UMLS:C2917659


subject: CHEBI:61160

subject_name: conjugated linolenic acid

object_name: asthma


subject: CHEBI:63005

subject_name: Sodium nitrate


subject: CHEBI:78870

subject_name: sodium nitrite


subject: PUBCHEM.COMPOUND:162623707

object_name: Safety Issues


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: aorta coarctation


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:229652

subject_name: Iptacopan

object_name: atypical hemolytic-uremic syndrome


subject: UMLS:C0352868

subject_name: Metronidazole gel

object_name: Periodontal Pocket


subject: UNII:A10SJL62JY

subject_name: Ocrelizumab

object_name: Pathologic Processes


subject: UNII:H4C81M8YYW

object_name: osteoarthritis, knee


subject: CHEBI:76607

subject_name: Macitentan

object_name: cardiac allograft vasculopathy


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Aggressive Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805

object_name: mantle cell lymphoma


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: CHEBI:41879


subject: UMLS:C5555534

object_name: plasma cell myeloma


subject: CHEBI:8988

object_name: primary brain neoplasm


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:6801

subject_name: Metformin


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:90942

subject_name: Ixazomib

object_name: acute lymphoblastic leukemia


subject: UMLS:C5238315

object_name: metastatic colorectal cancer


subject: UNII:W0ZE0NT8IF

subject_name: Etrumadenant


subject: GTOPDB:12349

subject_name: zimberelimab


subject: UNII:ZBL7O904IL


subject: UMLS:C5204520


subject: CHEBI:38867

subject_name: anaesthetic

object_name: no feeling or sensation of skin


subject: CHEBI:38867

object_name: Sensory Loss


subject: CHEBI:38867

object_name: DNA Damage


subject: UMLS:C0002932

subject_name: Anesthetics


subject: UMLS:C0002932


subject: UMLS:C0002932


subject: UMLS:C4722058

subject_name: Anesthetics [TC]


subject: UMLS:C4722058


subject: UMLS:C4722058


subject: CHEBI:6375

subject_name: Lansoprazole

object_name: Gastrointestinal reflux


subject: CHEMBL.COMPOUND:CHEMBL5314347

subject_name: SEVELAMER CARBONATE

object_name: cardiovascular disorder


subject: UNII:9YCX42I8IU

subject_name: sevelamer carbonate


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b

object_name: type 1 diabetes mellitus 1


subject: UNII:43K1W2T1M6

object_name: type 1 diabetes mellitus


subject: UMLS:C1610033

subject_name: Interferon Alpha, Human


subject: UMLS:C1610033


subject: PR:000024938

subject_name: interferon alpha


subject: PR:000024938


subject: UMLS:C2825023

subject_name: Interferon alpha [EPC]


subject: UMLS:C2825023


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: Gastrointestinal motility disorder


subject: UMLS:C2703094

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C2703094

object_name: clear cell renal carcinoma


subject: UMLS:C2703094

object_name: renal cell adenocarcinoma


subject: UMLS:C2703094

object_name: renal cell carcinoma


subject: UMLS:C1541521

subject_name: AMG 386

object_name: non-small cell lung carcinoma


subject: CHEBI:88316

subject_name: Nefopam

object_name: breast neoplasm


subject: UNII:2946IE3VYD

object_name: acute leukemia


subject: UNII:2946IE3VYD

object_name: Myelodysplasia


subject: UNII:2946IE3VYD

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UNII:2946IE3VYD

object_name: acute myeloid leukemia by FAB classification


subject: UNII:2946IE3VYD

object_name: acute myeloid leukemia


subject: UNII:2946IE3VYD

object_name: acute lymphoblastic leukemia


subject: MESH:D016827

subject_name: CD8 Antigens


subject: MESH:D016827


subject: MESH:D016827


subject: MESH:D016827


subject: MESH:D016827


subject: MESH:D016827


subject: PUBCHEM.COMPOUND:46874763

object_name: pyelonephritis


subject: UMLS:C0003232

subject_name: Antibiotics


subject: CHEBI:91899

object_name: childhood acute lymphoblastic leukemia


subject: CHEBI:3207

subject_name: Budesonide


subject: PUBCHEM.COMPOUND:2307

subject_name: Andion


subject: CHEBI:3001

subject_name: beclomethasone


subject: UMLS:C0445115

subject_name: Normal saline

object_name: Emergencies


subject: CHEMBL.COMPOUND:CHEMBL5095385

subject_name: NANRILKEFUSP ALFA

object_name: colorectal cancer


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: colorectal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5417804

subject_name: RLI 15


subject: UMLS:C5417804


subject: UMLS:C5417804


subject: CHEBI:9014

subject_name: Salsalate

object_name: progressive supranuclear palsy


subject: CHEBI:8346

subject_name: Potassium Iodide

object_name: thyroid tumor


subject: CHEMBL.COMPOUND:CHEMBL2108391

subject_name: HONEY

object_name: Alveolalgia


subject: CHEBI:168442

subject_name: Urolithin A

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:168442

object_name: COPD, severe early onset


subject: CHEBI:168442

object_name: chronic obstructive pulmonary disease


subject: UMLS:C3273713

subject_name: Atinumab

object_name: acute spinal cord injury


subject: UMLS:C0071315

subject_name: Pneumovax

object_name: asthma


subject: UMLS:C0876134

subject_name: Prevnar


subject: CHEBI:133017

subject_name: Pimavanserin

object_name: pervasive developmental disorder


subject: CHEBI:133017

object_name: autism


subject: CHEBI:133017

object_name: autism spectrum disorder


subject: UMLS:C4080094

object_name: hepatitis C


subject: UMLS:C4080094

object_name: chronic hepatitis C virus infection


subject: GTOPDB:9296

subject_name: vunakizumab

object_name: EXCESS LMW-DNA


subject: CHEMBL.COMPOUND:CHEMBL4298102

subject_name: VUNAKIZUMAB


subject: UMLS:C4726978

subject_name: Vunakizumab


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: esophageal squamous cell carcinoma


subject: UMLS:C3827082


subject: UNII:6XG22YQM2Z

subject_name: TIRAGOLUMAB


subject: UMLS:C4331912


subject: UMLS:C0021665

subject_name: Insulin-Like Growth Factor I

object_name: Duchenne muscular dystrophy


subject: PR:000009182

subject_name: insulin-like growth factor 1


subject: CHEBI:33330

subject_name: scandium atom

object_name: Child Malnutrition


subject: PR:000007182

subject_name: erythroid membrane-associated protein


subject: PR:000050188

subject_name: polymeric immunoglobulin receptor secretory component


subject: UNII:N0JZU0WGU5

subject_name: Calmangafodipir

object_name: colorectal cancer


subject: UNII:N0JZU0WGU5

object_name: colorectal carcinoma


subject: UNII:N0JZU0WGU5

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:N0JZU0WGU5

object_name: Peripheral neuropathy due to and following antineoplastic therapy


subject: UNII:P28BIW0UTB

subject_name: FODIPIR


subject: UNII:P28BIW0UTB


subject: UNII:P28BIW0UTB


subject: CHEMBL.COMPOUND:CHEMBL4297714

subject_name: CALMANGAFODIPIR


subject: CHEMBL.COMPOUND:CHEMBL4297714


subject: CHEMBL.COMPOUND:CHEMBL4297714


subject: CHEMBL.COMPOUND:CHEMBL4297714


subject: CHEBI:73604

subject_name: Lys-Gly


subject: UMLS:C5445271

subject_name: Sardine Extract

object_name: Prediabetes


subject: UMLS:C5445271

object_name: type 2 diabetes mellitus


subject: UMLS:C5445271

object_name: Diabetes


subject: UMLS:C5445271

object_name: diabetes mellitus


subject: UNII:Q46947FE7K

subject_name: Peginterferon alfa-2a

object_name: thalassemia


subject: CHEBI:94463


subject: CHEBI:63580

subject_name: Ribavirin


subject: UMLS:C1328107

object_name: plasma cell myeloma


subject: CHEMBL.COMPOUND:CHEMBL4594340

subject_name: POSOLEUCEL

object_name: BK-virus nephropathy


subject: PUBCHEM.COMPOUND:124122366

object_name: cancer


subject: PUBCHEM.COMPOUND:124122366

object_name: neoplasm


subject: PUBCHEM.COMPOUND:124122366

object_name: colon carcinoma


subject: PUBCHEM.COMPOUND:124122366


subject: PUBCHEM.COMPOUND:124122366

object_name: colon cancer


subject: PUBCHEM.COMPOUND:124122366

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:124122366

object_name: exocrine pancreatic carcinoma


subject: PUBCHEM.COMPOUND:124122366

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:124122366

object_name: Malignant neoplasm of colon stage IV


subject: PUBCHEM.COMPOUND:124122366

object_name: Disseminated Malignant Neoplasm


subject: PUBCHEM.COMPOUND:124122366

object_name: Embolism, Tumor


subject: PUBCHEM.COMPOUND:124122366

object_name: Neoplasm Metastasis


subject: PUBCHEM.COMPOUND:124122366

object_name: colon cancer liver metastasis


subject: PUBCHEM.COMPOUND:124122366

object_name: Secondary malignant neoplasm of lung


subject: PUBCHEM.COMPOUND:124122366

object_name: Metastatic non-small cell lung cancer


subject: PUBCHEM.COMPOUND:124122366

object_name: Metastatic malignant neoplasm to pancreas


subject: PUBCHEM.COMPOUND:124122366

object_name: pancreatic adenocarcinoma


subject: PUBCHEM.COMPOUND:124122366

object_name: metastatic melanoma


subject: PUBCHEM.COMPOUND:124122366

object_name: Colon Neoplasm


subject: PUBCHEM.COMPOUND:124122366

object_name: Primary malignant neoplasm


subject: PUBCHEM.COMPOUND:124122366

object_name: neoplastic syndrome


subject: PUBCHEM.COMPOUND:124122366

object_name: childhood neoplasm


subject: PUBCHEM.COMPOUND:124122366

object_name: cancer or benign tumor


subject: CHEBI:177703

subject_name: Latanoprostene bunod

object_name: Disorder of intraocular pressure


subject: CHEBI:177703

object_name: Intraocular Pressure


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: aneurysm


subject: CHEBI:27812

subject_name: Methylselenocysteine

object_name: CTD-ILD


subject: MESH:C478920

object_name: Chronic small plaque psoriasis


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: Hodgkin Disease


subject: UMLS:C4086713

object_name: Adult Classical Hodgkin Lymphoma


subject: CHEBI:175901

subject_name: Gemcitabine


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: CHEBI:93786


subject: UMLS:C5884511

subject_name: Combogesic IV

object_name: Acute Pain


subject: CHEBI:52172

subject_name: Nilotinib

object_name: neurofibromatosis


subject: CHEBI:52172

object_name: neurofibromatosis 1


subject: CHEBI:52172

object_name: neurofibroma


subject: CHEBI:52172

object_name: neurofibromatosis type 1


subject: CHEBI:149509

object_name: Depressed mood


subject: CHEBI:149509

object_name: Cancer patients and suicide and depression


subject: CHEBI:149509

object_name: Depressed - symptom


subject: CHEBI:149509

object_name: Depression, CTCAE


subject: CHEBI:3347

subject_name: Candesartan


subject: CHEBI:3347


subject: CHEBI:3347


subject: CHEBI:3347


subject: CHEBI:9123

subject_name: Sertraline

object_name: hypertension


subject: CHEBI:9123

object_name: Hypertension, CTCAE


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: Acute Ischemic Stroke


subject: UNII:I031V2H011

object_name: Ischemic stroke


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: tumor suppressor gene on chromosome 11


subject: CHEBI:175901


subject: GTOPDB:8313

subject_name: talazoparib


subject: GTOPDB:8313

object_name: lung cancer


subject: UNII:5S371K6132

subject_name: Rivoceranib


subject: PUBCHEM.COMPOUND:72758394

subject_name: Ponesimod

object_name: multiple sclerosis


subject: CHEBI:139554

subject_name: magnetic nanoparticle

object_name: diarrhea


subject: CHEBI:139554

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:139554

object_name: Diarrhea, CTCAE


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: stricture


subject: CHEBI:4653

subject_name: Dipyridamole

object_name: coronary atherosclerosis


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Kaposi Sarcoma


subject: UMLS:C5707702

subject_name: CMV pp65 Peptide-loaded Alpha-type-1 Polarized Dendritic Cell Vaccine

object_name: cytomegalovirus infection


subject: UMLS:C5707702

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: osteoarthritis


subject: CHEBI:78320

subject_name: Lactic acid

object_name: Loss of hypoglycemic warning due to diabetes mellitus


subject: UMLS:C1176295

subject_name: Natrium lacticum, Homeopathic preparation


subject: CHEBI:61397

subject_name: Neratinib

object_name: metastatic malignant neoplasm in the brain


subject: UMLS:C2981830

subject_name: SGN 75

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C2981830

object_name: clear cell renal carcinoma


subject: UMLS:C2981830

object_name: renal cell adenocarcinoma


subject: CHEBI:229764

subject_name: Selinexor

object_name: non-small cell lung carcinoma


subject: CHEBI:3640

subject_name: Chlorothiazide

object_name: ADHF


subject: CHEBI:5778

subject_name: Hydrochlorothiazide


subject: CHEBI:6801

subject_name: Metformin

object_name: thyroid tumor


subject: UNII:21K6M2I7AG

subject_name: interferon gamma-1b

object_name: osteopetrosis


subject: UMLS:C0021741

subject_name: Actimmune


subject: CHEBI:135515

subject_name: Bendamustine

object_name: Plasma cell myeloma recurrent


subject: CHEBI:7773

subject_name: Ondansetron

object_name: Adverse reaction to other drugs and medicines


subject: UNII:A3ULP0F556

subject_name: Eculizumab

object_name: Hemolytic uremic syndrome of childhood


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: Interstitial pneumonitis


subject: CHEBI:61057

object_name: adult dermatomyositis


subject: CHEBI:61057

object_name: dermatomyositis


subject: CHEBI:61057

object_name: polymyositis


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: PUBCHEM.COMPOUND:134129840

subject_name: POLYMYXIN B

object_name: ventilator-associated pneumonia


subject: PUBCHEM.COMPOUND:4868

subject_name: polymyxin B


subject: CHEMBL.COMPOUND:CHEMBL5314354


subject: UMLS:C5239897

subject_name: Vaccine product containing only live attenuated Rotavirus antigen (medicinal product)

object_name: Rotavirus infection


subject: UMLS:C3257584

subject_name: Live Attenuated Rotavirus Vaccine [EPC]


subject: CHEBI:4445

subject_name: Desflurane

object_name: CORONARY ARTERY BYPASS GRAFT REDO


subject: CHEBI:4445

object_name: General anesthetic drug adverse reaction


subject: UNII:4A3702A96F

object_name: Parkinson disease


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: Duchenne muscular dystrophy


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: Non-small cell lung cancer stage III


subject: UNII:5TAA004E22

object_name: neoplasm


subject: UMLS:C5853662


subject: UMLS:C5853662

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C5853662


subject: PR:000022507

subject_name: protease ElaD

object_name: hepatitis


subject: PR:000022507

object_name: Chronic hepatitis


subject: PR:000022507

object_name: Acute hepatitis


subject: CHEBI:143658

object_name: Lymphoblastic leukemia in children


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:32660

subject_name: asparaginase


subject: PR:000002033

subject_name: band 3 anion transport protein


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:31822

subject_name: MERCAPTOPURINE


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: CHEBI:74073

subject_name: Ile-Met


subject: CHEBI:30366

subject_name: imidazolide


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: UNII:PTC9GTD4E7

subject_name: SALANERSEN

object_name: spinal muscular atrophy


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: childhood neoplasm


subject: PUBCHEM.COMPOUND:2767

object_name: neoplastic syndrome


subject: PUBCHEM.COMPOUND:2767

object_name: cancer or benign tumor


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: CHEBI:4672


subject: UMLS:C3853885


subject: UMLS:C3853885


subject: UMLS:C3853885


subject: UMLS:C3853885


subject: UNII:96265TNH2R

subject_name: Gedatolisib


subject: UNII:96265TNH2R


subject: UNII:96265TNH2R


subject: UNII:96265TNH2R


subject: CHEBI:135515

subject_name: Bendamustine

object_name: refractory hairy cell leukemia


subject: CHEBI:135515

object_name: testicular lymphoma


subject: CHEBI:135515

object_name: intraocular lymphoma


subject: CHEBI:135515

object_name: small intestine lymphoma


subject: CHEBI:135515

object_name: primary cutaneous B-cell lymphoma


subject: CHEBI:135515

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: CHEBI:135515

object_name: hepatosplenic T-cell lymphoma


subject: CHEBI:135515

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:135515

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:135515

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:135515

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:135515

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:135515

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:135515

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:135515

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:135515

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:135515

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: CHEBI:135515

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: CHEBI:135515

object_name: Lymphomatous Involvement of Non-Cutaneous Extranodal Site


subject: CHEBI:135515

object_name: Adult Solid Neoplasm


subject: CHEBI:135515

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:135515

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:62880

subject_name: Veliparib

object_name: Plasma cell myeloma refractory


subject: CHEBI:62880

object_name: refractory hairy cell leukemia


subject: CHEBI:62880

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:62880

object_name: testicular lymphoma


subject: CHEBI:62880

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:62880

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:62880

object_name: anaplastic large cell lymphoma


subject: CHEBI:62880

object_name: intraocular lymphoma


subject: CHEBI:62880

object_name: small intestine lymphoma


subject: CHEBI:62880

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:62880

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:62880

object_name: primary cutaneous B-cell lymphoma


subject: CHEBI:62880

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: CHEBI:62880

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:62880

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:62880

object_name: hepatosplenic T-cell lymphoma


subject: CHEBI:62880

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:62880

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:62880

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:62880

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:62880

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:62880

object_name: MALT lymphoma


subject: CHEBI:62880

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:62880

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:62880

object_name: splenic marginal zone lymphoma


subject: CHEBI:62880

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:62880

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:62880

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:62880

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:62880

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:62880

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:62880

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:62880

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: CHEBI:62880

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: CHEBI:62880

object_name: Lymphomatous Involvement of Non-Cutaneous Extranodal Site


subject: CHEBI:62880

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:62880

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:62880

object_name: Waldenstrom macroglobulinemia


subject: PUBCHEM.COMPOUND:126456119

subject_name: Lactoferrin

object_name: chronic liver failure


subject: PR:000009978

subject_name: lactotransferrin


subject: UMLS:C0022942

subject_name: lactoferrin


subject: UniProtKB:Q8TCD2

subject_name: LTF protein, human


subject: UMLS:C0721124

subject_name: Iron Supplement

object_name: iron deficiency anemia


subject: UMLS:C0721124


subject: UMLS:C2825025

subject_name: Iron Supplement [EPC]


subject: UMLS:C2825025


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: circadian rhythm sleep disorder


subject: CHEBI:16796

subject_name: Melatonin


subject: UMLS:C0961899

object_name: multiple sclerosis


subject: UNII:C8ADC441ME

subject_name: Ivabradine

object_name: Permanent atrial fibrillation


subject: CHEBI:73803

subject_name: Ala-Asp

object_name: neurodegenerative disease


subject: CHEBI:73803

object_name: Lewy Bodies


subject: CHEBI:73803

object_name: Alzheimer disease type 1


subject: CHEBI:73803

object_name: Alzheimer disease


subject: CHEBI:27666

subject_name: Dactinomycin


subject: CHEBI:27666


subject: CHEBI:27666


subject: CHEBI:27666


subject: UMLS:C1630418

subject_name: AD Substance


subject: UMLS:C1630418


subject: UMLS:C1630418


subject: UMLS:C1630418


subject: CHEBI:8405

subject_name: Primaquine

object_name: favism


subject: CHEBI:3175

subject_name: Brimonidine

object_name: diabetic retinopathy


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Childhood Glioblastoma


subject: CHEBI:31348

object_name: adult glioblastoma


subject: CHEBI:31348

object_name: Intracranial glioma


subject: CHEBI:31348

object_name: primary brain neoplasm


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Stiff shoulders


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: CHEBI:9570

subject_name: Thiotepa

object_name: CD4+/CD56+ hematodermic neoplasm


subject: CHEBI:9570

object_name: mixed phenotype acute leukemia


subject: CHEBI:9570

object_name: Malignant myeloproliferative neoplasm


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED


subject: UMLS:C0812735


subject: CHEBI:46081

subject_name: Fluconazole


subject: CHEBI:46081


subject: CHEBI:47519

subject_name: Ketoconazole


subject: MESH:C010491

subject_name: neurotropin

object_name: complex regional pain syndrome type 1


subject: MESH:C010491

object_name: causalgia


subject: CHEBI:107736

subject_name: Metoclopramide

object_name: Abnormality of extrapyramidal motor function


subject: CHEBI:41423

subject_name: Celecoxib

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UNII:1EF190B6M7

subject_name: PLASMINOGEN

object_name: ligneous conjunctivitis


subject: CHEBI:42567

subject_name: Fisetin

object_name: severe acute respiratory syndrome


subject: CHEBI:31348

object_name: Cervix carcinoma recurrent


subject: CHEBI:31348

object_name: cervical adenosquamous carcinoma


subject: CHEBI:60802

subject_name: ropivacaine

object_name: chronic pain (diagnosis)


subject: CHEBI:60802

object_name: Chronic pain


subject: UMLS:C1172402

subject_name: TS-1 titanium silicide

object_name: recurrent gastric cancer


subject: UMLS:C2828372


subject: UNII:1C25MR0H0E

object_name: interstitial cystitis


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: Out-of-Hospital Cardiac Arrest


subject: CHEBI:174615

object_name: Lymphoma, Extranodal NK-T-Cell


subject: CHEBI:28901

subject_name: Busulfan


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Carcinoma breast stage IV


subject: CHEBI:7774

subject_name: Zofran


subject: CHEBI:7774


subject: CHEBI:7773

subject_name: Ondansetron


subject: CHEBI:7773


subject: CHEBI:5855

subject_name: Ibuprofen

object_name: Burn injury


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: metastatic neoplasm


subject: UNII:PQX0D8J21J

object_name: Locally Advanced Malignant Neoplasm


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: CHEBI:175901

subject_name: Gemcitabine


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:91450

subject_name: Sapanisertib

object_name: Lung squamous cell carcinoma recurrent


subject: CHEBI:91450

object_name: Stage IV Lung Squamous Cell Carcinoma AJCC v7


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Injection site irritation


subject: CHEBI:46195

subject_name: Acetaminophen


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C5238055

subject_name: Tengonermin

object_name: Solid Neoplasm


subject: UMLS:C1143119

subject_name: Zafiride


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: Haemolysis neonatal


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: mucosal melanoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Uveal Melanoma AJCC v7


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255


subject: MESH:C520255

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: PUBCHEM.COMPOUND:72995949

subject_name: Voclosporin

object_name: psoriasis


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: De Novo Myelodysplastic Syndrome


subject: UNII:M89N0Q7EQR

object_name: Secondary Myelodysplastic Syndrome


subject: UNII:M89N0Q7EQR

object_name: Childhood Acute Myeloid Leukemia without Maturation


subject: UNII:M89N0Q7EQR

object_name: childhood acute myeloid leukemia with maturation


subject: UNII:M89N0Q7EQR

object_name: untreated childhood acute myeloid leukemia and other myeloid malignancies


subject: UNII:M89N0Q7EQR

object_name: Childhood Acute Myelomonocytic Leukemia


subject: UNII:M89N0Q7EQR

object_name: Childhood Acute Monoblastic Leukemia


subject: UNII:M89N0Q7EQR

object_name: childhood acute monocytic leukemia


subject: UNII:M89N0Q7EQR

object_name: Childhood Acute Erythroid Leukemia


subject: UNII:M89N0Q7EQR

object_name: childhood acute megakaryoblastic leukemia


subject: UNII:M89N0Q7EQR

object_name: myelodysplastic syndrome with ring sideroblasts


subject: UNII:M89N0Q7EQR

object_name: Myelodysplastic syndrome with low blasts (disorder)


subject: UNII:M89N0Q7EQR

object_name: myelodysplastic syndrome with single lineage dysplasia


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: CHEBI:32660

subject_name: asparaginase

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:32660

object_name: chronic myelomonocytic leukemia


subject: CHEBI:32660

object_name: refractory anemia with excess blasts in transformation


subject: CHEBI:32660

object_name: myelodysplastic syndrome with excess blasts


subject: CHEBI:32660


subject: CHEBI:32660


subject: CHEBI:32660


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:17650

object_name: childhood myelodysplastic syndrome


subject: CHEBI:17650

object_name: Secondary Myelodysplastic Syndrome


subject: CHEBI:17650

object_name: Childhood Acute Myeloid Leukemia without Maturation


subject: CHEBI:17650

object_name: childhood acute myeloid leukemia with maturation


subject: CHEBI:17650

object_name: untreated childhood acute myeloid leukemia and other myeloid malignancies


subject: CHEBI:17650

object_name: Childhood Acute Myelomonocytic Leukemia


subject: CHEBI:17650

object_name: Childhood Acute Monoblastic Leukemia


subject: CHEBI:17650

object_name: childhood acute monocytic leukemia


subject: CHEBI:17650

object_name: Childhood Acute Erythroid Leukemia


subject: CHEBI:17650

object_name: childhood acute megakaryoblastic leukemia


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:17650

object_name: Myelodysplastic syndrome with low blasts (disorder)


subject: CHEBI:17650

object_name: myelodysplastic syndrome with single lineage dysplasia


subject: UNII:464OXX39Y6

subject_name: Dinalbuphine sebacate

object_name: Arthropathy of knee joint


subject: PUBCHEM.COMPOUND:72760162

subject_name: Nalbuphine sebacate


subject: CHEBI:7507

subject_name: Framycetin

object_name: vaginitis


subject: PUBCHEM.COMPOUND:4568

subject_name: Nystatin A1


subject: CHEMBL.COMPOUND:CHEMBL5465559

subject_name: NYSTATIN


subject: CHEBI:7660

subject_name: nystatin


subject: CHEBI:28645

subject_name: FRUCTOSE

object_name: type 1 diabetes mellitus 1


subject: CHEBI:28645

object_name: Complications of Diabetes Mellitus


subject: CHEBI:48095

subject_name: keto-D-fructose


subject: CHEBI:48095


subject: CHEBI:4798

subject_name: Entacapone

object_name: schizophrenia


subject: UMLS:C3896730

object_name: oral cavity squamous cell carcinoma


subject: CHEBI:28001

subject_name: Vancomycin

object_name: Clostridium difficile infection recurrence


subject: UMLS:C0059079

subject_name: EMLA

object_name: non-Hodgkin lymphoma


subject: UMLS:C0059079

object_name: leukemia


subject: UMLS:C0059079

object_name: childhood leukemia


subject: CHEBI:95021

subject_name: pemetrexed

object_name: chordoma


subject: CHEBI:63724


subject: UMLS:C1705207

subject_name: Endostar

object_name: digestive system neoplasm


subject: UMLS:C1705207

object_name: Neoplasm of the gastrointestinal tract


subject: UMLS:C3896824

subject_name: Anti c-KIT Antibody-drug Conjugate LOP628

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:90200922

object_name: asthma


subject: PUBCHEM.COMPOUND:90200922

object_name: chronic obstructive pulmonary disease


subject: UNII:6ZE7T2VQ9F


subject: UNII:6ZE7T2VQ9F


subject: CHEBI:28925

subject_name: Mechlorethamine

object_name: lichen planopilaris


subject: UMLS:C5417806

subject_name: Recombinant Bacterial Minicells VAX014

object_name: bladder transitional cell carcinoma


subject: UMLS:C5417806

object_name: transitional cell carcinoma


subject: UMLS:C4725070

subject_name: Polyamine Transport Inhibitor AMXT-1501 Dicaprate

object_name: Neuroblastoma recurrent


subject: UMLS:C4725070

object_name: Ewing sarcoma


subject: UMLS:C4725070

object_name: Osteosarcoma recurrent


subject: UMLS:C4725070

object_name: ependymoblastoma


subject: UMLS:C4725070

object_name: embryonal tumor with multilayered rosettes


subject: UMLS:C4725070

object_name: atypical teratoid rhabdoid tumor


subject: UMLS:C4725070

object_name: Childhood Atypical Teratoid/Rhabdoid Tumor


subject: UMLS:C4725070

object_name: diffuse midline glioma, H3 K27M-mutant


subject: UMLS:C4725070

object_name: diffuse intrinsic pontine glioma


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Acute anterior ST segment elevation myocardial infarction


subject: UMLS:C2346820


subject: UMLS:C4084344

subject_name: Adzenys XR-ODT

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UMLS:C4084344


subject: CHEBI:151

subject_name: ISOCITRIC ACID

object_name: Cardiac complication


subject: CHEBI:151

object_name: myocarditis


subject: CHEBI:151

object_name: viral myocarditis


subject: CHEBI:151

object_name: Myocarditis, CTCAE 5.0


subject: CHEBI:151

object_name: Myocarditis, CTCAE 3.0


subject: CHEBI:8461

subject_name: Promethazine

object_name: post operative nausea and vomiting


subject: CHEBI:136053

subject_name: Nemonoxacin

object_name: Abnormal renal physiology


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: osteoarthritis, knee


subject: UMLS:C0384570

subject_name: Recombinant Human Growth Hormone


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C2825029

subject_name: Recombinant Human Growth Hormone [EPC]


subject: CHEBI:31550

subject_name: Patupilone

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:31355

subject_name: Carboplatin

object_name: adenosquamous carcinoma


subject: CHEBI:31355

object_name: large cell carcinoma


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:177298

object_name: DNA Damage Response Gene Mutation


subject: CHEBI:177298

object_name: DNA Repair Gene Mutation


subject: CHEBI:177298

object_name: GEN1 Gene Mutation


subject: CHEBI:177298

object_name: FANCD2 Gene Mutation


subject: CHEBI:177298

object_name: FANCL Gene Mutation


subject: CHEBI:177298

object_name: RAD51C Gene Mutation


subject: CHEBI:177298

object_name: CHEK1 Gene Mutation


subject: CHEBI:177298

object_name: ATM Gene Mutation


subject: CHEBI:177298

object_name: RAD51 Gene Mutation


subject: CHEBI:177298

object_name: NBN Gene Mutation


subject: CHEBI:177298

object_name: CDK12 Gene Mutation


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:3286

subject_name: Cabergoline

object_name: ACTH-producing pituitary gland adenoma


subject: UMLS:C2240391

subject_name: Herbal medicine (product)

object_name: iron deficiency anemia


subject: UMLS:C5435258

object_name: diabetic macular edema


subject: CHEBI:91414

subject_name: Adavosertib

object_name: Stage II Cervical Cancer AJCC v7


subject: CHEBI:91414

object_name: Stage IIA Cervical Cancer AJCC v7


subject: CHEBI:91414

object_name: Stage IB Cervical Cancer AJCC v6 and v7


subject: CHEBI:91414

object_name: Stage IB2 Cervical Cancer


subject: CHEBI:91414

object_name: Stage I Vaginal Cancer AJCC v6 and v7


subject: CHEBI:91414

object_name: Stage IIB Cervical Cancer AJCC v6 and v7


subject: CHEBI:91414

object_name: Stage III Cervical Cancer AJCC v6 and v7


subject: CHEBI:91414

object_name: Stage IIIA Cervical Cancer AJCC v6 and v7


subject: CHEBI:91414

object_name: Stage IIIB Cervical Cancer AJCC v6 and v7


subject: CHEBI:91414

object_name: Stage II Vaginal Cancer AJCC v6 and v7


subject: CHEBI:91414

object_name: Stage III Vaginal Cancer AJCC v6 and v7


subject: CHEBI:91414

object_name: vaginal carcinoma


subject: CHEBI:91414

object_name: Stage I Uterine Corpus Cancer


subject: CHEBI:91414

object_name: Stage IA Uterine Corpus Cancer AJCC v7


subject: CHEBI:91414

object_name: Stage II Uterine Corpus Cancer


subject: CHEBI:91414

object_name: Stage IB Uterine Corpus Cancer AJCC v7


subject: CHEBI:91414

object_name: Stage III Uterine Corpus Cancer


subject: CHEBI:91414

object_name: Stage IIIC Uterine Corpus Cancer AJCC v7


subject: CHEBI:91414

object_name: Stage IIIB Uterine Corpus Cancer AJCC v7


subject: CHEBI:91414

object_name: Stage IIIA Uterine Corpus Cancer AJCC v7


subject: CHEBI:91414

object_name: female reproductive organ cancer


subject: CHEBI:91414

object_name: endometrioid adenocarcinoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Stage IB2 Cervical Cancer


subject: PUBCHEM.COMPOUND:2767

object_name: Stage I Vaginal Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: GTOPDB:13305

subject_name: linvoseltamab

object_name: Relapsed/refractory multiple myeloma


subject: UNII:M3CPC50MZS

subject_name: LINVOSELTAMAB


subject: UMLS:C4764258

subject_name: Linvoseltamab


subject: CHEBI:18358

subject_name: Methoxsalen

object_name: HIV infection


subject: HMDB:HMDB0013470

subject_name: LPS with O-antigen

object_name: post-traumatic stress disorder


subject: CHEBI:16412

subject_name: Lysophosphotidylserine


subject: PUBCHEM.COMPOUND:155977629


subject: CHEBI:89981

subject_name: Endotoxins


subject: UMLS:C5700426

subject_name: furmonertinib

object_name: Oligoprogression


subject: CHEBI:15365

subject_name: Aspirin

object_name: neoplasm


subject: CHEBI:62880

subject_name: Veliparib

object_name: non-small cell lung carcinoma


subject: CHEBI:16526

subject_name: Carbon dioxide

object_name: sickle cell disease


subject: CHEBI:16526

object_name: brain disorder


subject: CHEBI:137245

subject_name: Asp-Pro

object_name: metastatic colorectal cancer


subject: CHEBI:4653

subject_name: Dipyridamole


subject: PUBCHEM.COMPOUND:118224238

object_name: Metastatic Melanoma in the Brain


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: triple-negative breast carcinoma


subject: CHEBI:201431

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:201431

object_name: DNA Damage Response Deficiency


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:6121

subject_name: Ketamine

object_name: digestive system disorder


subject: CHEBI:6121

object_name: respiratory system disorder


subject: CHEBI:95165

object_name: Pancreatic adenocarcinoma metastatic


subject: UNII:0NIZ8H6OL8

subject_name: Tetrahydrouridine


subject: CHEBI:135673

subject_name: Rupatadine

object_name: cold urticaria


subject: CHEBI:39867

subject_name: Valproic acid

object_name: heart valve disorder


subject: CHEBI:39867

object_name: multiple organ dysfunction syndrome


subject: CHEBI:39867

object_name: coronary artery disorder


subject: CHEBI:39867

object_name: coronary atherosclerosis


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Lennox-Gastaut syndrome


subject: CHEBI:16796

subject_name: Melatonin


subject: PUBCHEM.COMPOUND:444033

subject_name: Ciclesonide


subject: CHEBI:32599

object_name: brain injury


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Episiotomy wound


subject: CHEBI:94518

object_name: Immediate Postpartum Hemorrhage


subject: CHEBI:94518

object_name: Hemoglobin finding


subject: CHEBI:94518

object_name: Hemoglobin, CTCAE


subject: CHEBI:94518

object_name: hemoglobin measurement


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Stage IVC Nasopharyngeal Carcinoma AJCC v7


subject: CHEBI:231614

object_name: Stage IV Nasopharyngeal Carcinoma AJCC v7


subject: CHEBI:231614

object_name: Stage III Nasopharyngeal Carcinoma AJCC v7


subject: CHEBI:231614

object_name: Stage IVB Nasopharyngeal Carcinoma AJCC v7


subject: CHEBI:231614

object_name: Stage IVA Nasopharyngeal Carcinoma AJCC v7


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:76004

subject_name: Dimethyl fumarate

object_name: Acute Ischemic Stroke


subject: CHEBI:76004

object_name: Ischemic stroke


subject: CHEBI:6073

subject_name: Isradipine

object_name: bipolar disorder


subject: CHEBI:133017

subject_name: Pimavanserin

object_name: Parkinson disease


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: Premature Labor


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: nicotine dependence


subject: CHEBI:29287

subject_name: Gold

object_name: Depressed mood


subject: CHEBI:29287

object_name: Cancer patients and suicide and depression


subject: CHEBI:29287

object_name: Depressed - symptom


subject: CHEBI:29287

object_name: Depression, CTCAE


subject: CHEBI:8214

subject_name: Pindolol


subject: CHEBI:8214


subject: CHEBI:8214


subject: CHEBI:8214


subject: UNII:349552KRHK

subject_name: Simendan

object_name: myocardial infarction


subject: UNII:349552KRHK

object_name: Myocardial Infarction, CTCAE


subject: UNII:349552KRHK

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:193746


subject: CHEBI:193746


subject: CHEBI:193746


subject: CHEBI:50567

subject_name: Levosimendan


subject: CHEBI:50567


subject: CHEBI:50567


subject: UMLS:C4310418

object_name: Hepatic impairment


subject: UMLS:C4721495

subject_name: Astugenal

object_name: mixed glioma


subject: UNII:16VY3TM7ZO

subject_name: Antineoplaston A10


subject: UMLS:C4721487

subject_name: ATENGENAL


subject: CHEBI:32599

object_name: Pesticide poisoning


subject: CHEBI:7575

subject_name: Nimodipine


subject: UNII:V5Y646AW8S

object_name: Postoperative cognitive dysfunction


subject: CHEBI:2618

subject_name: Amantadine


subject: CHEBI:6538

subject_name: Loratadine


subject: UMLS:C0678145

subject_name: Clexane

object_name: venous thromboembolism


subject: UMLS:C0678145

object_name: thrombophilia due to thrombin defect


subject: UMLS:C1615613

object_name: non-Hodgkin lymphoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: intravascular large B-cell lymphoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:47898

subject_name: Epirubicin


subject: CHEBI:8382

subject_name: Prednisone


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:36373

subject_name: vindesine


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib


subject: UMLS:C0032615

subject_name: Polyunsaturated Fatty Acids

object_name: chronic liver failure


subject: CHEBI:26208

subject_name: polyunsaturated fatty acid


subject: CHEBI:4875

subject_name: Etanercept

object_name: Sicca Syndrome


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: UMLS:C4553893

subject_name: Fumaria (substance)

object_name: Pruritus, CTCAE


subject: UMLS:C4553893

object_name: Pruritus


subject: UMLS:C4553893

object_name: end stage renal failure


subject: UMLS:C4553893

object_name: Chronic uremia


subject: CHEBI:4875

object_name: discoid lupus erythematosus


subject: CHEBI:4875

object_name: cutaneous lupus erythematosus


subject: PR:000001959


subject: PR:000001959


subject: CHEBI:7465

subject_name: Naltrexone

object_name: metastatic prostate carcinoma


subject: CHEBI:6339

subject_name: Etoricoxib

object_name: Surgical wound


subject: CHEBI:6339

object_name: Surgical wound finding


subject: CHEBI:135145

subject_name: Neridronic Acid

object_name: osteoarthritis, knee


subject: CHEBI:8404

subject_name: Prilocaine

object_name: Surgical procedure finding


subject: CHEBI:8404

object_name: Post-Operative Pain


subject: CHEBI:8404

object_name: musculoskeletal system disorder


subject: PUBCHEM.COMPOUND:4739

subject_name: Vidarbine

object_name: Adult Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:4739

object_name: childhood myelodysplastic syndrome


subject: PUBCHEM.COMPOUND:4739

object_name: Myelodysplastic Syndrome, CTCAE


subject: PUBCHEM.COMPOUND:4739

object_name: acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:4739

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: PUBCHEM.COMPOUND:4739

object_name: acute myeloid leukemia


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:27834

subject_name: Pentostatin


subject: CHEBI:27834


subject: CHEBI:27834


subject: CHEBI:27834


subject: CHEBI:27834


subject: CHEBI:27834


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: Telangiectasia of macula lutea


subject: UNII:15C2VL427D

object_name: Macular telangiectasia


subject: CHEBI:28911

subject_name: cob(III)alamin

object_name: Overweight and obesity


subject: CHEBI:28911

object_name: lupus erythematosus


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: PUBCHEM.COMPOUND:165339223


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: HMDB:HMDB0000607


subject: CHEBI:176843

subject_name: vitamin B12


subject: CHEBI:176843


subject: UMLS:C0086024

subject_name: cobalamins


subject: UMLS:C0086024


subject: CHEBI:17439


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: UMLS:C2936883


subject: UMLS:C4733632

subject_name: Clostridium butyricum CBM 588 Probiotic Strain

object_name: cardiovascular disorder


subject: UMLS:C4733632

object_name: Mild depression


subject: UMLS:C0376659

subject_name: Cancer Vaccines

object_name: Childhood Glioblastoma


subject: CHEBI:32184

subject_name: Tazarotene

object_name: skin carcinoma


subject: UNII:AD0O8X2QJR

subject_name: Ubrogepant

object_name: Episodic migraine


subject: CHEBI:7454

subject_name: Nalbuphine

object_name: Hernia of the abdominal wall


subject: CHEBI:7454

object_name: Hernia


subject: CHEBI:7454

object_name: Consent Type - Hysterectomy


subject: UMLS:C0724588

subject_name: Recombinant Follicle Stimulating Hormone

object_name: anovulation


subject: UMLS:C0724588

object_name: Female infertility associated with anovulation


subject: UMLS:C0724588

object_name: Androgen excess


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: lung disorder


subject: CHEBI:135983

subject_name: Teriparatide

object_name: Fractured humerus


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Cancer of Neck


subject: CHEBI:5931

subject_name: insulin human

object_name: anterolateral myocardial infarction


subject: CHEBI:5931

object_name: myocardial infarction


subject: UMLS:C0876064

subject_name: Lantus


subject: UMLS:C0876064


subject: UMLS:C0876064

object_name: acute myocardial infarction


subject: UMLS:C1654827

subject_name: Apidra


subject: UMLS:C1654827


subject: UMLS:C1654827


subject: UMLS:C5401607

subject_name: Recombinant Bacterial ACE2 Receptors-like Enzyme


subject: CHEBI:6413

subject_name: Letrozole

object_name: adenomyosis


subject: CHEBI:6062

subject_name: Isosorbide mononitrate

object_name: Uses contraception (finding)


subject: UNII:T42P99266K

subject_name: METHYLENE BLUE

object_name: Postoperative cognitive dysfunction


subject: UNII:T42P99266K

object_name: Postoperative delirium


subject: UNII:T42P99266K

object_name: Emergence Delirium


subject: CHEBI:43830

subject_name: Methylthioninium


subject: CHEBI:43830


subject: CHEBI:43830


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: Ovarian and fallopian tube cysts and neoplasms


subject: UNII:GKF8S4C432

object_name: Neoplasm of the genitourinary tract


subject: UNII:GKF8S4C432

object_name: BRCA1 gene mutation


subject: UNII:GKF8S4C432

object_name: BRCA2 gene mutation


subject: UNII:GKF8S4C432

object_name: Adnexal Diseases


subject: CHEBI:83766

subject_name: Olaparib

object_name: ovarian disease


subject: CHEBI:83766


subject: CHEBI:83766

object_name: Epithelioma


subject: CHEBI:83766

object_name: Neoplasms by Histologic Type


subject: CHEBI:83766

object_name: female reproductive system disorder


subject: CHEBI:83766

object_name: female reproductive system neoplasm


subject: CHEBI:83766


subject: CHEBI:83766

object_name: carcinoma


subject: KEGG.COMPOUND:C02380

object_name: adult acute myeloid leukemia


subject: KEGG.COMPOUND:C02380

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: CHEBI:2208


subject: CHEBI:44423

subject_name: Hydroxyurea


subject: CHEBI:44423


subject: CHEBI:168243

subject_name: Valproic acid glucuronide


subject: CHEBI:168243


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:39867


subject: GTOPDB:8323

subject_name: monalizumab

object_name: head and neck neoplasm


subject: UNII:3ZXZ2V0588


subject: UMLS:C3896730


subject: UMLS:C4086550

subject_name: Pemlimogene merolisbac

object_name: lung adenocarcinoma


subject: UMLS:C0936150

subject_name: artemether / lumefantrine

object_name: Malaria, Vivax


subject: UNII:HVE36P8422

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UNII:HVE36P8422

object_name: obesity


subject: UNII:HVE36P8422

object_name: Obesity, CTCAE


subject: CHEBI:51230

subject_name: Bimatoprost

object_name: euthyroid Graves orbitopathy


subject: CHEBI:51230

object_name: endocrine exophthalmos


subject: UMLS:C0876134

subject_name: Prevnar

object_name: Invasive Streptococcus pneumoniae disease


subject: UMLS:C0876134

object_name: meningitis


subject: UMLS:C0876134

object_name: Meningitis, CTCAE


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: Optic Nerve Injuries


subject: CHEBI:32682

subject_name: L-argininium

object_name: osteoarthritis, knee


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:9927

subject_name: Valsartan

object_name: Prediabetes


subject: CHEBI:9927

object_name: glucose intolerance


subject: CHEBI:9927

object_name: Impaired glucose tolerance


subject: CHEBI:6129

subject_name: Ketorolac

object_name: nephrolithiasis, calcium oxalate


subject: CHEBI:6129

object_name: nephrolithiasis


subject: UMLS:C0359180

subject_name: albumin solution

object_name: c.surgical procedure; cardiac


subject: UNII:VOM9DP10M3

subject_name: Histamine glutarimide

object_name: asthma


subject: DRUGBANK:DB17341

object_name: Childhood Solid Neoplasm


subject: DRUGBANK:DB17341

object_name: Adult Solid Neoplasm


subject: DRUGBANK:DB17341

object_name: Solid Neoplasm


subject: DRUGBANK:DB17341

object_name: Childhood Soft Tissue Sarcoma


subject: DRUGBANK:DB17341

object_name: Adult Soft Tissue Sarcoma


subject: DRUGBANK:DB17341

object_name: sarcoma


subject: DRUGBANK:DB17341

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: DRUGBANK:DB17341

object_name: soft tissue sarcoma


subject: DRUGBANK:DB17341

object_name: malignant soft tissue neoplasm


subject: DRUGBANK:DB17341

object_name: Metastatic sarcoma


subject: UMLS:C2095775

subject_name: ampicillins

object_name: Fractures, Open


subject: CHEBI:28971

subject_name: Ampicillin


subject: PUBCHEM.COMPOUND:5316

subject_name: Sulbactam


subject: PUBCHEM.COMPOUND:5316

object_name: Surgical Wound Infection


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin


subject: PUBCHEM.COMPOUND:3467


subject: CHEBI:29007

subject_name: Ceftriaxone


subject: UNII:X00B0D5O0E

subject_name: PIPERACILLIN


subject: UNII:X00B0D5O0E


subject: CHEBI:8232

subject_name: Piperacillin


subject: CHEBI:8232


subject: CHEBI:9421

subject_name: Tazobactam


subject: CHEBI:9421


subject: CHEBI:135925

subject_name: Lisdexamfetamine

object_name: type 1 diabetes mellitus 1


subject: CHEBI:135925

object_name: type 1 diabetes mellitus


subject: CHEBI:6887

subject_name: Methylphenidate


subject: CHEBI:6887


subject: CHEBI:61397

subject_name: Neratinib

object_name: triple-negative breast carcinoma


subject: CHEBI:61397

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:232102

object_name: Drug Interactions


subject: CHEBI:232102

object_name: Adverse drug interaction


subject: PUBCHEM.COMPOUND:5464076


subject: PUBCHEM.COMPOUND:5464076


subject: CHEBI:53329


subject: CHEBI:53329


subject: PR:000009060

subject_name: insulin-like peptide INSL5


subject: PR:000009060


subject: PR:000013980

subject_name: Rho-related GTP-binding protein RhoF


subject: PR:000013980


subject: PR:000023845

subject_name: DNA-directed RNA polymerase subunit beta


subject: PR:000023845


subject: UniProtKB:P0A8V2

subject_name: RPOB_ECOLI DNA-directed RNA polymerase subunit beta (sprot)


subject: UniProtKB:P0A8V2


subject: UMLS:C3890420

subject_name: Realgar-Indigo naturalis Formulation


subject: UMLS:C3890420


subject: CHEBI:94534

subject_name: olanzapine

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:4856

subject_name: Esmolol

object_name: lumbar disc herniation


subject: CHEBI:6456

subject_name: Lidocaine


subject: UMLS:C0383956

subject_name: HBOC 201

object_name: Coronary Occlusion


subject: UMLS:C0383956

object_name: acute coronary syndrome


subject: UMLS:C5238017

subject_name: Hemoglobin glutamer-250 (bovine)


subject: UMLS:C5238017


subject: UMLS:C0663202

subject_name: Hemopure


subject: UMLS:C0663202


subject: CHEBI:177833

subject_name: Cilengitide

object_name: lung cancer


subject: CHEBI:177833

object_name: lung neoplasm


subject: CHEBI:177833

object_name: lung carcinoma


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: GTOPDB:12990

subject_name: sintilimab

object_name: Angiosarcoma recurrent


subject: GTOPDB:12990

object_name: Locally Advanced Angiosarcoma


subject: GTOPDB:12990

object_name: Metastatic angiosarcoma


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: UMLS:C4329335


subject: UMLS:C2976495

object_name: maturity-onset diabetes of the young type 1


subject: UMLS:C0525078

subject_name: MONTANIDE ISA 720

object_name: malaria


subject: UMLS:C4687480

subject_name: Nanoparticle Paclitaxel Ointment SOR007

object_name: cervical intraepithelial neoplasia


subject: UMLS:C4687480

object_name: dysplasia of cervix


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: Acute perforated appendicitis


subject: UNII:L500PR95QA

object_name: Appendicitis Perforated, CTCAE


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: UMLS:C0219461

subject_name: regramostim

object_name: Ruptured Appendicitis


subject: UMLS:C0219461


subject: UMLS:C0219461


subject: UNII:4FR53SIF3A

subject_name: Blinatumomab

object_name: lymphoma, non-Hodgkin, familial


subject: UNII:4FR53SIF3A

object_name: non-Hodgkin lymphoma


subject: UNII:4FR53SIF3A

object_name: Adult Non-Hodgkin Lymphoma


subject: UNII:4FR53SIF3A

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:15355

subject_name: Acetylcholine

object_name: Childhood Breast Carcinoma


subject: CHEBI:15355

object_name: breast carcinoma


subject: CHEBI:15355

object_name: breast cancer


subject: CHEBI:15355

object_name: adult lymphoma


subject: CHEBI:15355

object_name: lymphoma


subject: CHEBI:15355

object_name: pediatric lymphoma


subject: CHEBI:15355

object_name: leukemia


subject: CHEBI:15355

object_name: childhood leukemia


subject: CHEBI:32682

subject_name: L-argininium


subject: CHEBI:32682


subject: CHEBI:32682


subject: CHEBI:32682


subject: CHEBI:32682


subject: CHEBI:32682


subject: CHEBI:32682


subject: CHEBI:32682


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:29952


subject: CHEBI:29952


subject: CHEBI:29952


subject: CHEBI:29952


subject: CHEBI:29952


subject: CHEBI:29952


subject: CHEBI:29952


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:16467


subject: CHEBI:16467


subject: CHEBI:16467


subject: CHEBI:16467


subject: CHEBI:16467


subject: CHEBI:16467


subject: CHEBI:16467


subject: CHEBI:30105

subject_name: diazo group


subject: CHEBI:30105


subject: CHEBI:30105


subject: CHEBI:30105


subject: CHEBI:30105


subject: CHEBI:30105


subject: CHEBI:30105


subject: CHEBI:30105


subject: CHEBI:30227

subject_name: azanediidyl group


subject: CHEBI:30227


subject: CHEBI:30227


subject: CHEBI:30227


subject: CHEBI:30227


subject: CHEBI:30227


subject: CHEBI:30227


subject: CHEBI:30227


subject: CHEBI:29276


subject: CHEBI:29276


subject: CHEBI:29276


subject: CHEBI:29276


subject: CHEBI:29276


subject: CHEBI:29276


subject: CHEBI:29276


subject: CHEBI:29276


subject: CHEBI:52556

subject_name: p-tolyl group


subject: CHEBI:52556


subject: CHEBI:52556


subject: CHEBI:52556


subject: CHEBI:52556


subject: CHEBI:52556


subject: CHEBI:52556


subject: CHEBI:52556


subject: CHEBI:29825

subject_name: sulfonyl group


subject: CHEBI:29825


subject: CHEBI:29825


subject: CHEBI:29825


subject: CHEBI:29825


subject: CHEBI:29825


subject: CHEBI:29825


subject: CHEBI:29825


subject: CHEBI:25248

subject_name: methyl ester


subject: CHEBI:25248


subject: CHEBI:25248


subject: CHEBI:25248


subject: CHEBI:25248


subject: CHEBI:25248


subject: CHEBI:25248


subject: CHEBI:25248


subject: CHEBI:29321

subject_name: sodium nitroprusside


subject: CHEBI:29321


subject: CHEBI:29321


subject: CHEBI:29321


subject: CHEBI:29321


subject: CHEBI:29321


subject: CHEBI:29321


subject: CHEBI:29321


subject: UNII:EAO03PE1TC

subject_name: Sodium nitroprusside hydrate


subject: UNII:EAO03PE1TC


subject: UNII:EAO03PE1TC


subject: UNII:EAO03PE1TC


subject: UNII:EAO03PE1TC


subject: UNII:EAO03PE1TC


subject: UNII:EAO03PE1TC


subject: UNII:EAO03PE1TC


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: PR:000014196

subject_name: eukaryotic-type large ribosomal subunit protein uL22

object_name: carcinoma


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: GTOPDB:4985


subject: PR:000001379


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: PUBCHEM.COMPOUND:152165

object_name: Biceps tendonitis


subject: PUBCHEM.COMPOUND:152165

object_name: Rotator Cuff Tendinitis


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:47381


subject: UNII:EGC16R10V0

subject_name: DALANTERCEPT

object_name: Advanced Adult Hepatocellular Carcinoma


subject: UMLS:C2981815

subject_name: Dalantercept


subject: UMLS:C3658170

object_name: psoriatic arthritis


subject: CHEBI:167309

subject_name: Methadone

object_name: Thoracolumbar scoliosis


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: endometrial clear cell adenocarcinoma


subject: CHEBI:41879

object_name: clear cell adenocarcinoma


subject: UMLS:C1572744

subject_name: LEUTEIN

object_name: age-related macular degeneration


subject: CHEBI:47781

subject_name: Desipramine

object_name: major depressive disorder


subject: CHEBI:47781

object_name: endogenous depression


subject: MESH:C000720888

object_name: Hypercholesterolemia


subject: CHEBI:131156

object_name: cancer


subject: CHEBI:131156

object_name: neoplasm


subject: PUBCHEM.COMPOUND:6435378

subject_name: iloprost

object_name: Heart failure with normal ejection fraction


subject: UMLS:C5226695

object_name: rheumatoid arthritis


subject: UNII:4U7K5X4ANS

subject_name: Emeramide

object_name: Chronic obstructive pulmonary disease of horses


subject: UNII:4U7K5X4ANS

object_name: COPD, severe early onset


subject: UNII:4U7K5X4ANS

object_name: chronic obstructive pulmonary disease


subject: UNII:4U7K5X4ANS

object_name: copd bronchitis


subject: CHEBI:49005

subject_name: Deferasirox

object_name: Poor Prognosis Metastatic Gestational Trophoblastic Tumor


subject: CHEBI:49005

object_name: Recurrent Ovarian Germ Cell Tumor


subject: CHEBI:49005

object_name: Testis cancer recurrent


subject: CHEBI:49005

object_name: stage III testicular cancer


subject: CHEBI:49005

object_name: MALT lymphoma


subject: CHEBI:49005


subject: CHEBI:49005

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:49005

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:49005

object_name: Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma


subject: CHEBI:49005

object_name: Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:49005

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:49005

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:49005

object_name: Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:49005

object_name: Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma


subject: CHEBI:49005

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:49005

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:49005

object_name: Stage III Adult Immunoblastic Lymphoma


subject: CHEBI:49005

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: CHEBI:49005

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:49005

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:49005

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:49005

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:49005

object_name: Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma


subject: CHEBI:49005

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:49005

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: CHEBI:49005

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:49005

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: CHEBI:49005

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:49005

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:49005

object_name: Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma


subject: CHEBI:49005

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:49005

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:49005

object_name: Adult Acute Lymphoblastic Leukemia in Remission


subject: CHEBI:49005

object_name: Blast Phase


subject: CHEBI:49005

object_name: Secondary Myelodysplastic Syndrome


subject: CHEBI:49005

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:49005

object_name: Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma


subject: CHEBI:49005

object_name: Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma


subject: CHEBI:49005

object_name: Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma


subject: CHEBI:49005

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:49005

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:49005

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:49005

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:49005

object_name: Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma


subject: CHEBI:49005

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:49005

object_name: Mantle cell lymphoma stage III


subject: CHEBI:49005

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:49005

object_name: refractory hairy cell leukemia


subject: CHEBI:49005

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:49005

object_name: Mantle cell lymphoma stage IV


subject: CHEBI:49005

object_name: Adult Acute Myeloid Leukemia in Remission


subject: CHEBI:49005

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:49005

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:49005

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: CHEBI:49005

object_name: Chronic lymphocytic leukaemia stage 3


subject: CHEBI:49005

object_name: Recurrent ovarian cancer


subject: CHEBI:49005

object_name: Chronic lymphocytic leukaemia stage 4


subject: CHEBI:49005

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: CHEBI:49005

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:49005

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:49005

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:49005

object_name: B-cell small lymphocytic lymphoma stage III


subject: CHEBI:49005

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:49005

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:49005

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:49005

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:49005

object_name: B-cell small lymphocytic lymphoma stage IV


subject: CHEBI:49005

object_name: Ovarian cancer stage III


subject: CHEBI:49005

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:49005

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:49005

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:49005

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:49005

object_name: Ovarian epithelial cancer stage II


subject: CHEBI:49005

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:49005

object_name: Ovarian cancer stage IV


subject: CHEBI:49005

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: CHEBI:49005

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: CHEBI:49005

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: CHEBI:49005

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: CHEBI:49005

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: CHEBI:49005

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: CHEBI:49005

object_name: Marginal zone lymphoma stage III


subject: CHEBI:49005

object_name: Marginal zone lymphoma stage IV


subject: CHEBI:49005

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:49005

object_name: chronic myelomonocytic leukemia


subject: CHEBI:49005

object_name: splenic marginal zone lymphoma


subject: CHEBI:49005

object_name: Stage III Adult Hodgkin Lymphoma


subject: CHEBI:49005

object_name: Stage III Adult Burkitt Lymphoma


subject: CHEBI:49005

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:49005

object_name: Stage IV Adult Hodgkin Lymphoma


subject: CHEBI:49005

object_name: Stage IV Adult Burkitt Lymphoma


subject: CHEBI:49005

object_name: chronic neutrophilic leukemia


subject: CHEBI:49005

object_name: chronic eosinophilic leukemia


subject: CHEBI:49005

object_name: ISS Stage III Plasma Cell Myeloma


subject: CHEBI:49005

object_name: DS Stage III Plasma Cell Myeloma


subject: CHEBI:49005

object_name: Disseminated neuroblastoma


subject: CHEBI:49005

object_name: Stage 4S neuroblastoma


subject: CHEBI:49005

object_name: Neuroblastoma recurrent


subject: CHEBI:49005

object_name: DS Stage II Plasma Cell Myeloma


subject: CHEBI:49005

object_name: ISS Stage II Plasma Cell Myeloma


subject: CHEBI:49005

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:49005

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:49005

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:49005

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:49005

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:49005

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:49005

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:49005

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:49005

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:49005

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:49005

object_name: DS Stage I Plasma Cell Myeloma


subject: CHEBI:49005

object_name: ISS Stage I Plasma Cell Myeloma


subject: CHEBI:49005

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:49005

object_name: Carcinoma breast stage IV


subject: CHEBI:49005

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:49005

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:49005

object_name: myelofibrosis


subject: PUBCHEM.COMPOUND:133082063

subject_name: Apitoxin

object_name: Allergy to bee venom


subject: UMLS:C0004920

subject_name: Bee Venoms


subject: UNII:W0655Y0HSJ

subject_name: Calcium DTPA

object_name: Cognitive Disturbance, CTCAE 3.0


subject: UNII:W0655Y0HSJ

object_name: Cognitive impairment


subject: UNII:W0655Y0HSJ

object_name: Cognitive Disturbance, CTCAE 5.0


subject: UNII:W0655Y0HSJ

object_name: hyperpigmentation of the skin


subject: UNII:W0655Y0HSJ

object_name: Skin Hyperpigmentation, CTCAE


subject: UNII:W0655Y0HSJ

object_name: Arthralgia


subject: UNII:W0655Y0HSJ

object_name: Arthralgia, CTCAE


subject: UNII:W0655Y0HSJ

object_name: Headache


subject: UNII:W0655Y0HSJ

object_name: Headache, CTCAE


subject: UNII:G79YN26H5B


subject: UNII:G79YN26H5B


subject: UNII:G79YN26H5B


subject: UNII:G79YN26H5B


subject: UNII:G79YN26H5B


subject: UNII:G79YN26H5B


subject: UNII:G79YN26H5B


subject: UNII:G79YN26H5B


subject: UNII:G79YN26H5B


subject: CHEBI:35739

subject_name: Pentetic acid


subject: CHEBI:35739


subject: CHEBI:35739


subject: CHEBI:35739


subject: CHEBI:35739


subject: CHEBI:35739


subject: CHEBI:35739


subject: CHEBI:35739


subject: CHEBI:35739


subject: UNII:NXU65IC8PG

subject_name: pentetate zinc trisodium


subject: UNII:NXU65IC8PG


subject: UNII:NXU65IC8PG


subject: UNII:NXU65IC8PG


subject: UNII:NXU65IC8PG


subject: UNII:NXU65IC8PG


subject: UNII:NXU65IC8PG


subject: UNII:NXU65IC8PG


subject: UNII:NXU65IC8PG


subject: UMLS:C2348637

subject_name: TLR9 Agonist SD-101

object_name: hepatitis C


subject: UMLS:C2348637

object_name: chronic hepatitis C virus infection


subject: CHEBI:233364

subject_name: Bryostatin

object_name: HIV infection


subject: CHEBI:88353

subject_name: Bryostatin 1


subject: UNII:8M7YSN2KII

subject_name: nortramadol


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: CHEBI:3757

subject_name: Clonidine

object_name: BH4-deficient hyperphenylalaninemia A


subject: UMLS:C3896904

subject_name: Fluorine F 18 L-glutamate Derivative BAY94-9392

object_name: neoplasm


subject: UNII:7UWT6B0L2U

subject_name: ETOKIMAB

object_name: pulmonary eosinophilia


subject: UNII:7UWT6B0L2U

object_name: Asthmatic pulmonary eosinophilia


subject: UMLS:C5238218

subject_name: Etokimab


subject: UMLS:C5238218


subject: UNII:J7M4Z2D183

subject_name: Aroplatin

object_name: cancer


subject: UNII:J7M4Z2D183

object_name: B-cell non-Hodgkin lymphoma


subject: UNII:J7M4Z2D183

object_name: B-cell neoplasm


subject: DRUGBANK:DB17319


subject: DRUGBANK:DB17319


subject: DRUGBANK:DB17319


subject: CHEBI:60481


subject: PR:000008953

subject_name: insulin-like growth factor-binding protein 7


subject: UMLS:C3858051

subject_name: ledipasvir / sofosbuvir


subject: CHEBI:6801

subject_name: Metformin

object_name: prostate neoplasm


subject: UMLS:C5554944

subject_name: Pan-FGFR Inhibitor ICP-192

object_name: Advanced Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:90647162

object_name: NUT Carcinoma


subject: PUBCHEM.COMPOUND:90647162


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: respiratory tract infectious disorder


subject: CHEBI:6432

subject_name: Levamisole


subject: PUBCHEM.COMPOUND:137229597

subject_name: Inosine pranobex


subject: UMLS:C0795760

subject_name: Isoprinosine


subject: CHEMBL.COMPOUND:CHEMBL4594569

subject_name: AMLITELIMAB

object_name: dermatitis


subject: CHEMBL.COMPOUND:CHEMBL4594569

object_name: Eczema, CTCAE


subject: UMLS:C5555444

subject_name: Amlitelimab


subject: UMLS:C5555444


subject: UMLS:C5854375

subject_name: Modified Interleukin-2 LTC004


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: Thrombolysis in Myocardial Infarction Flow


subject: UMLS:C4721782

subject_name: Pegargiminase

object_name: malignant pleural mesothelioma


subject: UMLS:C1328192

subject_name: ADI PEG20


subject: UNII:9X7O8V25IT

subject_name: collagenase

object_name: cutis laxa


subject: UMLS:C0009053

subject_name: collagenase Clostridium histolyticum


subject: CHEBI:76609

subject_name: Aprocitentan

object_name: Drug Interactions


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Reactive oxygen species 1 positive non-small cell lung cancer


subject: CHEBI:31355

object_name: ROS1 gene rearrangement


subject: CHEBI:31355

object_name: ALK gene rearrangement positive


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: Epidermal growth factor receptor positive non-small cell lung cancer


subject: CHEBI:85994


subject: CHEBI:85994


subject: CHEBI:85994


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: UMLS:C5198356

subject_name: PEGylated carboxyhemoglobin bovine

object_name: Chronic uremia


subject: UMLS:C5198792

subject_name: Sanguinate


subject: CHEBI:76016

subject_name: Vortioxetine

object_name: panic disorder


subject: CHEBI:76016

object_name: panic disorder 1


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: Venous thrombosis after immobility


subject: CHEBI:28364

subject_name: Icosapent

object_name: Arrhythmia


subject: CHEBI:37144

subject_name: epichlorohydrin


subject: CHEBI:37144

object_name: coronary artery disorder


subject: CHEBI:37144

object_name: coronary atherosclerosis


subject: PR:000016352

subject_name: metalloproteinase inhibitor 1


subject: PR:000016352


subject: PR:000016352


subject: CHEBI:36005

subject_name: docosahexaenoic acid


subject: CHEBI:36005


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:16016


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:28125


subject: CHEBI:84498

subject_name: poly(cytidylic acid)

object_name: Neoplasm Metastasis


subject: CHEBI:84498

object_name: liver neoplasm


subject: CHEBI:84498

object_name: Neoplasm Recurrence, Local


subject: CHEBI:181445

subject_name: Cytosine arabinoside monophosphate


subject: CHEBI:181445


subject: CHEBI:181445


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: schizophreniform disorder


subject: CHEBI:7421

subject_name: NAC

object_name: schizophrenia


subject: CHEBI:7421


subject: CHEBI:7421

object_name: schizoaffective disorder


subject: CHEBI:7421

object_name: schizophrenia 18


subject: CHEBI:47519

subject_name: Ketoconazole


subject: CHEBI:6775

subject_name: Mesalazine

object_name: Diverticular Diseases


subject: CHEBI:6775

object_name: Diverticulosis


subject: PUBCHEM.COMPOUND:9832804

subject_name: Enstilar

object_name: Chronic small plaque psoriasis


subject: CHEBI:90855


subject: RXCUI:1716093

subject_name: betamethasone / calcipotriene Topical Foam


subject: UMLS:C2756353

subject_name: NeutraSal

object_name: Xerostomia


subject: UMLS:C1881373

subject_name: Synthetic Levothyroxine

object_name: brain neoplasm


subject: CHEBI:18332

subject_name: Levothyroxine


subject: CHEBI:18258

subject_name: Liothyronine


subject: UMLS:C0108555

subject_name: Casein Kinase II

object_name: renal carcinoma


subject: UMLS:C0108555

object_name: kidney neoplasm


subject: UMLS:C0108555

object_name: kidney cancer


subject: CHEBI:63717

subject_name: Tenofovir disoproxil

object_name: HIV Seronegativity


subject: CHEBI:6715

subject_name: medroxyprogesterone

object_name: arteriovenous hemangioma/malformation


subject: DRUGBANK:DB10989

subject_name: Hepatitis A Vaccine

object_name: streptococcal infection


subject: UMLS:C0170300

subject_name: Hepatitis A Vaccines


subject: CHEBI:49140

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:49140

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:49140

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:49140

object_name: Stage III renal cell cancer


subject: CHEBI:49140

object_name: Stage III Renal Cell Cancer AJCC v7


subject: CHEBI:49140

object_name: Progesterone Receptor Negative


subject: CHEBI:49140

object_name: Estrogen Receptor Negative


subject: CHEBI:49140

object_name: triple-negative breast carcinoma


subject: CHEBI:49140

object_name: Stage III Pleural Malignant Mesothelioma AJCC v7


subject: CHEBI:49140

object_name: Stage IV Pleural Malignant Mesothelioma AJCC v7


subject: CHEBI:49140

object_name: HER2/Neu Negative


subject: CHEBI:49140

object_name: B-cell neoplasm


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617


subject: UNII:92T1Y5X038

subject_name: Florilglutamic acid F-18


subject: UNII:92T1Y5X038


subject: UNII:92T1Y5X038

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UNII:92T1Y5X038

object_name: Carcinoma breast stage IV


subject: UNII:92T1Y5X038

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UNII:92T1Y5X038

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UNII:92T1Y5X038

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UNII:92T1Y5X038

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UNII:92T1Y5X038

object_name: Stage IIIA Breast Carcinoma


subject: UNII:92T1Y5X038

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UNII:92T1Y5X038

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UNII:92T1Y5X038

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UNII:92T1Y5X038

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UNII:92T1Y5X038

object_name: Stage IV Renal Cell Cancer


subject: UNII:92T1Y5X038

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UNII:92T1Y5X038

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UNII:92T1Y5X038

object_name: Stage III Renal Cell Cancer AJCC v8


subject: UNII:92T1Y5X038

object_name: Stage III renal cell cancer


subject: UNII:92T1Y5X038

object_name: Stage III Renal Cell Cancer AJCC v7


subject: UNII:92T1Y5X038

object_name: Non-small cell lung cancer stage IIIA


subject: UNII:92T1Y5X038

object_name: Non-small cell lung cancer stage IIIB


subject: UNII:92T1Y5X038

object_name: Metastatic non-small cell lung cancer


subject: UNII:92T1Y5X038

object_name: Progesterone Receptor Negative


subject: UNII:92T1Y5X038

object_name: Estrogen Receptor Negative


subject: UNII:92T1Y5X038

object_name: triple-negative breast carcinoma


subject: UNII:92T1Y5X038

object_name: Stage III Pleural Malignant Mesothelioma AJCC v7


subject: UNII:92T1Y5X038

object_name: Stage IV Pleural Malignant Mesothelioma AJCC v7


subject: UNII:92T1Y5X038

object_name: HER2/Neu Negative


subject: UNII:92T1Y5X038

object_name: B-cell neoplasm


subject: UMLS:C4053691

object_name: Metastatic Renal Cell Carcinoma


subject: UMLS:C4053691

object_name: Metastatic Renal Cell Cancer


subject: UMLS:C4053691

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C4053691

object_name: Carcinoma breast stage IV


subject: UMLS:C4053691

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C4053691

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C4053691

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C4053691

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C4053691

object_name: Stage IIIA Breast Carcinoma


subject: UMLS:C4053691

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UMLS:C4053691

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UMLS:C4053691

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C4053691

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C4053691

object_name: Stage IV Renal Cell Cancer


subject: UMLS:C4053691

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UMLS:C4053691

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UMLS:C4053691

object_name: Stage III Renal Cell Cancer AJCC v8


subject: UMLS:C4053691

object_name: Stage III renal cell cancer


subject: UMLS:C4053691

object_name: Stage III Renal Cell Cancer AJCC v7


subject: UMLS:C4053691

object_name: Non-small cell lung cancer stage IIIA


subject: UMLS:C4053691

object_name: Non-small cell lung cancer stage IIIB


subject: UMLS:C4053691

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C4053691

object_name: Progesterone Receptor Negative


subject: UMLS:C4053691

object_name: Estrogen Receptor Negative


subject: UMLS:C4053691

object_name: triple-negative breast carcinoma


subject: UMLS:C4053691

object_name: Stage III Pleural Malignant Mesothelioma AJCC v7


subject: UMLS:C4053691

object_name: Stage IV Pleural Malignant Mesothelioma AJCC v7


subject: UMLS:C4053691

object_name: HER2/Neu Negative


subject: UMLS:C4053691

object_name: B-cell neoplasm


subject: UMLS:C5139812

object_name: Metastatic Renal Cell Carcinoma


subject: UMLS:C5139812

object_name: Metastatic Renal Cell Cancer


subject: UMLS:C5139812

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C5139812

object_name: Carcinoma breast stage IV


subject: UMLS:C5139812

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C5139812

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C5139812

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C5139812

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C5139812

object_name: Stage IIIA Breast Carcinoma


subject: UMLS:C5139812

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UMLS:C5139812

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UMLS:C5139812

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C5139812

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C5139812

object_name: Stage IV Renal Cell Cancer


subject: UMLS:C5139812

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UMLS:C5139812

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UMLS:C5139812

object_name: Stage III Renal Cell Cancer AJCC v8


subject: UMLS:C5139812

object_name: Stage III renal cell cancer


subject: UMLS:C5139812

object_name: Stage III Renal Cell Cancer AJCC v7


subject: UMLS:C5139812

object_name: Non-small cell lung cancer stage IIIA


subject: UMLS:C5139812

object_name: Non-small cell lung cancer stage IIIB


subject: UMLS:C5139812

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C5139812

object_name: Progesterone Receptor Negative


subject: UMLS:C5139812

object_name: Estrogen Receptor Negative


subject: UMLS:C5139812

object_name: triple-negative breast carcinoma


subject: UMLS:C5139812

object_name: Stage III Pleural Malignant Mesothelioma AJCC v7


subject: UMLS:C5139812

object_name: Stage IV Pleural Malignant Mesothelioma AJCC v7


subject: UMLS:C5139812

object_name: HER2/Neu Negative


subject: UMLS:C5139812

object_name: B-cell neoplasm


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin

object_name: Gastrointestinal discomfort


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin


subject: UMLS:C2348756

subject_name: Testosterone Gel

object_name: 46, XY female


subject: CHEBI:149504

object_name: Ascites


subject: CHEBI:149504

object_name: Ascites, CTCAE


subject: CHEBI:149504

object_name: alcoholic liver cirrhosis


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: CHEBI:6541


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C0013227


subject: UMLS:C0013227


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C4287792

object_name: bladder tumor


subject: UMLS:C4526708


subject: CHEBI:28911

subject_name: cob(III)alamin

object_name: hepatitis C


subject: CHEBI:28911

object_name: chronic hepatitis C virus infection


subject: CHEBI:28911

object_name: Flaviviridae infectious disease


subject: CHEBI:28911

object_name: RNA Virus Infections


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: PUBCHEM.COMPOUND:165339223


subject: PUBCHEM.COMPOUND:165339223


subject: PUBCHEM.COMPOUND:165339223


subject: CHEBI:17439

subject_name: Cyanocobalamin


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: CHEBI:89324


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: nonpapillary renal cell carcinoma


subject: UNII:KXG2PJ551I

object_name: clear cell renal carcinoma


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: CHEBI:177298

object_name: lung cancer


subject: CHEBI:177298

object_name: lung neoplasm


subject: CHEBI:177298

object_name: lung carcinoma


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:176844


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab


subject: UNII:P0GVQ9A4S5


subject: UNII:P0GVQ9A4S5


subject: UNII:P0GVQ9A4S5

object_name: Mesothelioma


subject: UNII:P0GVQ9A4S5

object_name: mesothelial neoplasm


subject: UNII:P0GVQ9A4S5

object_name: malignant mesothelioma


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C0354604

subject_name: oral anticoagulants

object_name: atrial septal defect, ostium secundum type


subject: UMLS:C0354604

object_name: patent foramen ovale


subject: UMLS:C0354604

object_name: Cryptogenic Ischemic Stroke


subject: CHEBI:33325

subject_name: radium atom

object_name: Embolism, Tumor


subject: CHEBI:33325

object_name: Metastatic Lesion


subject: UMLS:C3827153


subject: UMLS:C3827153


subject: CHEBI:24261

subject_name: glucocorticoid


subject: MESH:C539751

subject_name: ankaferd blood stopper

object_name: Oral Mucositis


subject: MESH:C539751

object_name: stomatitis


subject: MESH:C539751

object_name: oral mucositis


subject: MESH:C539751

object_name: Effects of chemotherapy


subject: MESH:C539751

object_name: colon carcinoma


subject: MESH:C539751

object_name: colorectal cancer


subject: MESH:C539751

object_name: colon cancer


subject: CHEBI:6456

subject_name: Lidocaine

object_name: type 2 diabetes mellitus


subject: CHEBI:6456

object_name: Diabetes


subject: CHEBI:6456

object_name: diabetes mellitus


subject: MESH:C024632

subject_name: Espumisan

object_name: Stomach cancer


subject: MESH:C024632

object_name: gastric cancer


subject: UMLS:C4721945

subject_name: perflutren, human albumin microspheres

object_name: heart disorder


subject: UMLS:C2348756

subject_name: Testosterone Gel

object_name: impotence


subject: UMLS:C2348756

object_name: Erectile Dysfunction, CTCAE


subject: UMLS:C2348756

object_name: Erectile dysfunction


subject: UMLS:C2348756

object_name: Testosterone deficiency


subject: UMLS:C2348756

object_name: Testosterone Deficiency, CTCAE